ClassID:

21573

A61K51/082 - CPC Classification

Classification description:

Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being a RGD-containing peptide

Recent Application in this class:
#1
20260108641
2026-04-23

PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF

#2
20250352677
2025-11-20

METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES

#3
20250332298
2025-10-30

PEPTIDE-COUPLED ALGINATE GELS COMPRISING RADIONUCLIDES

#4
20250332296
2025-10-30

ZWITTERIONIC METAL CHELATORS

#5
20250332295
2025-10-30

ZWITTERIONIC METAL CHELATORS

#6
20250295821
2025-09-25

TARGETED RADIOPHARMACEUTICAL FOR TUMOR AND ITS USE IN THE IMAGING-GUIDED COMBINATION THERAPY OF TARGETED RADIOTHERAPY AND IMMUNOTHERAPY

#7
20250186633
2025-06-12

METHODS FOR IMAGING INTEGRIN EXPRESSION AND FOR IMAGING SITES OF ENDOMETRIOSIS

#8
20250161504
2025-05-22

RGD DIMER COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

#9
20250108136
2025-04-03

METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES

#10
20250090696
2025-03-20

MACROCYCLIC LIGANDS WITH PENDANT CHELATING MOIETIES AND COMPLEXES THEREOF

#11
20250082795
2025-03-13

COMBINATIONS OF IMAGING AGENT CONJUGATES AND APPLICATION THEREOF

#12
20250082792
2025-03-13

ZWITTERIONIC METAL CHELATORS

#13
20250082204
2025-03-13

IMAGING SYSTEMS AND METHODS FOR TISSUE DIFFERENTIATION, E.G., FOR INTRAOPERATIVE VISUALIZATION

#14
20240335571
2024-10-10

PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY

#15
20240299599
2024-09-12

DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY

#16
20240190897
2024-06-13

NITROGEN-CONTAINING MACROCYCLIC CONJUGATES AS RADIOPHARMACEUTICALS

#17
20240165277
2024-05-23

Methods and kits for preparing radionuclide complexes

#18
20240101601
2024-03-28

BI-TERMINAL PEGYLATED INTEGRIN-BINDING PEPTIDES AND METHODS OF USE THEREOF

#19
20230348378
2023-11-02

SMALL MOLECULE ALBUMIN BINDERS

#20
20230183317
2023-06-15

METHODS OF DETECTING AND TREATING LUNG DAMAGE IN RESPIRATORY-RELATED VIRAL INFECTIONS

#21
20230173113
2023-06-08

CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO

#22
20230117927
2023-04-20

Targeted Radiopharmaceutical for Tumor and Its Use in the Imaging-guided Combination Therapy of Targeted Radiotherapy and Immunotherapy

#23
20220339304
2022-10-27

Methods and kits for preparing radionuclide complexes

#24
20220305126
2022-09-29

Method for removing acetaldehyde

#25
20220133919
2022-05-05

ONE STEP 64Cu-BaBaSar-RGD2 PRODUCTION METHOD

#26
20220062445
2022-03-03

SUBSTITUTED ORGANOFLUOROBORATES AS IMAGING AGENTS

#27
20220054663
2022-02-24

METHOD FOR LABELING OF SENSITIVE AND THERMOSENSITIVE TARGETING BIOMOLECULES WITH TECHNETIUM BASED COMPOUNDS

#28
20210363161
2021-11-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#29
20210340181
2021-11-04

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

#30
20210308287
2021-10-07

Method for extraction and purification of 68GA

#31
20210206804
2021-07-08

Bi-terminal pegylated integrin-binding peptides and methods of use thereof

#32
20210138094
2021-05-13

Methods and kits for preparing radionuclide complexes

#33
20210060189
2021-03-04

Radiopharmaceutical compositions

#34
20210023171
2021-01-28

Peptides and related compositions and methods

#35
20210002328
2021-01-07

Peptide therapies for reduction of macular thickening

#36
20200405887
2020-12-31

Macrocyclic ligands with pendant chelating moieties and complexes thereof

#37
20200254055
2020-08-13

Pharmaceutical compositions and preparations for administration to the eye

#38
20200237921
2020-07-30

Method for removing acetaldehyde

#39
20200231543
2020-07-23

Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

#40
20200222564
2020-07-16

Compound Amphiphilic Peptide Nanomicelle, Preparation and Use Thereof

#41
20200222563
2020-07-16

Substituted organofluoroborates as imaging agents

#42
20200188540
2020-06-18

CONFORMATIONALLY STRAINED TRANS-CYCLOALKENES FOR RADIOLABELING

#43
20200179514
2020-06-11

PHTHALOCYANINE PROBES AND USES THEREOF

#44
20200155714
2020-05-21

DUAL-TARGET IMAGING MOLECULAR PROBE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF

#45
20200115391
2020-04-16

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#46
20200101180
2020-04-02

Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof

#47
20200078479
2020-03-12

Method for labeling of sensitive and thermosensitive targeting biomolecules with technetium based compounds

#48
20190343916
2019-11-14

Peptides useable for treatment of disorders of the eye

#49
20190309018
2019-10-10

Peptides useable for treating cancer

#50
20190282711
2019-09-19

Targeting peptides and methods of use

#51
20190240359
2019-08-08

One step 64Cu-BaBaSar-RGD2 production method

#52
20190231903
2019-08-01

IMAGING SYSTEMS AND METHODS FOR PARTICLE-DRIVEN, KNOWLEDGE-BASED, AND PREDICTIVE CANCER RADIOGENOMICS

#53
20190225625
2019-07-25

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#54
20190211057
2019-07-11

Targeted prodrug cytosine deaminase fusion carrier and application thereof

#55
20190160188
2019-05-30

Radiolabeled Alpha-Melanocyte Stimulating Hormone Hybrid Peptide for Melanoma Targeting

#56
20190134240
2019-05-09

Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy

#57
20190134239
2019-05-09

Pre-targeting strategies for molecular imaging and/or radioimmunotherapy

#58
20190090750
2019-03-28

IMAGING SYSTEMS AND METHODS FOR TISSUE DIFFERENTIATION, E.G., FOR INTRAOPERATIVE VISUALIZATION

#59
20190084931
2019-03-21

Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents

#60
20180339048
2018-11-29

Therapeutic and Diagnostic Probes

#61
20180305405
2018-10-25

Conjugates of RGD peptides and (bacterio)chlorophyll photosensitizers

#62
20180303902
2018-10-25

ENGINEERED INTEGRIN BINDING PEPTIDE COMPOSITIONS

#63
20180193410
2018-07-12

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

#64
20180185523
2018-07-05

Method for imaging arthritis

#65
20180092996
2018-04-05

METHODS AND KITS FOR PREPARING RADIONUCLIDE COMPLEXES

#66
20180037608
2018-02-08

Modified cyclopentapeptides and uses thereof

#67
20170360943
2017-12-21

Method for removing acetaldehyde

#68
20170267699
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#69
20170267698
2017-09-21

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#70
20170239378
2017-08-24

Fluorescent silica-based nanoparticles

#71
20170189567
2017-07-06

Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same

#72
20170174723
2017-06-22

Bi-terminal pegylated integrin-binding peptides and methods of use thereof

#73
20170095581
2017-04-06

Bispecific peptide conjugate and radioactive bispecific peptide imaging agent

#74
20170087259
2017-03-30

Radiolabeled alpha-melanocyte stimulating hormone hybrid peptide for melanoma targeting

#75
20170044080
2017-02-16

RADIOCONJUGATION METHOD

#76
20160251378
2016-09-01

Transmetalation methods for the synthesis of PET and SPECT imaging agents

#77
20160235871
2016-08-18

Spect radionuclide-labeled trimeric cycle RGD peptide, preparation method thereof and imaging method thereof

#78
20160206736
2016-07-21

Ligands to radiation-induced molecules

#79
20160206692
2016-07-21

Engineered integrin binding peptide compositions

#80
20160038619
2016-02-11

Substituted organofluoroborates as imaging agents

#81
20160022847
2016-01-28

Radiotracer compositions

#82
20160022846
2016-01-28

IODINE RADIOLABELLING METHOD

#83
20160022763
2016-01-28

Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to RGD binding sites

#84
20160015838
2016-01-21

Vinylsulfone-based 18F-labeling compositions and methods and uses thereof

#85
20150374819
2015-12-31

Phthalocyanine probes and uses thereof

#86
20150343084
2015-12-03

Therapeutic and diagnostic probes

#87
20150291608
2015-10-15

Tetraaza macrocyclic compound, preparation method thereof and use thereof

#88
20150265731
2015-09-24

Method to improve the tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting

#89
20150151011
2015-06-04

Preparation of Technetium-99M Tricarbonyl Labeled Glycine Monomer or Oligomer Containing Probes That Have Biomolecules and Its Application as Imaging Complex-Composition

#90
20150139902
2015-05-21

PURIFICATION OF [18F] - FLUCICLATIDE

#91
20150112043
2015-04-23

Small peptide specific for lung cancer and application thereof

#92
20150051392
2015-02-19

Functionalisation of cage amine ligands for metallo-radiopharmaceuticals

#93
20140377178
2014-12-25

Radiofluorination method

#94
20140377177
2014-12-25

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#95
20140369929
2014-12-18

Ligands to radiation-induced molecules

#96
20140154181
2014-06-05

RGD-containing peptidomimetics and uses thereof

#97
20140105819
2014-04-17

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#98
20140010757
2014-01-09

Imaging methods using engineered integrin binding peptides

#99
20140004039
2014-01-02

RGD mimetic γ-AApeptides and methods of use

#100
20130343989
2013-12-26

Methods and compositions related to internalizing RGD peptides

#101
20130259804
2013-10-03

Radiotracer compositions

#102
20130259803
2013-10-03

Radioconjugation method

#103
20130129623
2013-05-23

Radiopharmaceutical compositions

#104
20130129621
2013-05-23

Integrin receptor antagonists and their methods of use

#105
20130064766
2013-03-14

Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof

#106
20130039848
2013-02-14

Fluorescent silica-based nanoparticles

#107
20130004423
2013-01-03

Polyazamacrocyclic compound, and a production method and a biomedical use therefor

#108
20120294801
2012-11-22

Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses

#109
20120288445
2012-11-15

RADIOLABELLING

#110
20120283490
2012-11-08

System, device and method for preparing tracers and transferring materials during radiosynthesis

#111
20120282178
2012-11-08

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#112
20120220785
2012-08-30

Sultone compound derivatives substituted by nucleophiles, in particular radionuclides, and use thereof for marking macromolecules

#113
20120219495
2012-08-30

Tetraaza macrocyclic compound, preparation method thereof and use thereof

#114
20120214969
2012-08-23

Methods and compositions for F-18 labeling of proteins, peptides and molecules

#115
20120195828
2012-08-02

Kidney-imaging agent comprising recombinant gelatin

#116
20120156132
2012-06-21

Targeting agent to newly formed blood vessels

#117
20120134923
2012-05-31

Radioiodination method

#118
20120134920
2012-05-31

Methods and compositions for improved F labeling of proteins, peptides and other molecules

#119
20120107237
2012-05-03

Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same

#120
20120089017
2012-04-12

LIGANDS TO RADIATION-INDUCED MOLECULES

#121
20120076727
2012-03-29

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

#122
20120065367
2012-03-15

Radioactively Labeled Substance

#123
20120020882
2012-01-26

Peptide-based compounds

#124
20110313130
2011-12-22

Bifunctional chelating agents

#125
20110293517
2011-12-01

Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

#126
20110280801
2011-11-17

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#127
20110256057
2011-10-20

Cyclic azapeptides as integrin markers and methods of using

#128
20110236311
2011-09-29

Radiolabelling methods

#129
20110223102
2011-09-15

MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY

#130
20110213293
2011-09-01

Ligands to radiation-induced molecules

#131
20110182989
2011-07-28

Peptide compositions and therapeutic uses thereof

#132
20110110854
2011-05-12

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

#133
20110064658
2011-03-17

RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors

#134
20100316565
2010-12-16

Imaging method

#135
20100256330
2010-10-07

Peptide-based compounds

#136
20100196271
2010-08-05

Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same

#137
20100074910
2010-03-25

Achievement of a high therapeutic index through molecular imaging guided targeted drug treatment

#138
20100074844
2010-03-25

Cyclopeptides containing RGD mimetics as imaging markers for integrins

#139
20100068139
2010-03-18

Methods of radiofluorination of biologically active vectors

#140
20100015058
2010-01-21

RADIOLABELED BBN-RGD HETERODIMERS FOR CANCER TARGETING

#141
20090311177
2009-12-17

Radiolabelling methods

#142
20090299033
2009-12-03

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#143
20090263320
2009-10-22

Peptide-based compounds

#144
20090257952
2009-10-15

Engineered integrin binding peptides

#145
20090246133
2009-10-01

Methods and compositions related to internalizing RGD peptides

#146
20090246130
2009-10-01

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#147
20090203584
2009-08-13

Peptide-based compounds

#148
20090155166
2009-06-18

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#149
20090074664
2009-03-19

Cyclic azapeptides as integrin markers

#150
20090028788
2009-01-29

Compounds having RD targeting motifs

#151
20080274046
2008-11-06

Radiolabelling

#152
20080267882
2008-10-30

Imaging compounds, methods of making imaging compounds, methods of imaging, therapeutic compounds, methods of making therapeutic compounds, and methods of therapy

#153
20080253964
2008-10-16

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

#154
20080193377
2008-08-14

Radiolabeled Nanohybrids Targeting Solid Tumor Neovasculature and Method of Using Same

#155
20080187493
2008-08-07

Peptide-based compounds

#156
20080170992
2008-07-17

Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins

#157
20070104645
2007-05-10

Chelate based scaffolds in tumor targeting

#158
20070065361
2007-03-22

Ligands to radiation-induced molecules

#159
20060104898
2006-05-18

Ligands to radiation-induced molecules

#160
20060040324
2006-02-23

Methods for making metallopeptides and metallopeptide libraries

#161
20060029544
2006-02-09

Receptor-binding cyclic peptides and methods of use

#162
20060003926
2006-01-05

Pharmaceuticals for the imaging of angiogenic disorders

#163
20050118100
2005-06-02

Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent

#164
20050070466
2005-03-31

Peptide-based compounds

#165
20050069494
2005-03-31

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy